Spelman, T., Herring, W., Acosta, C., Hyde, R., Jokubaitis, V., Pucci, E., Lugaresi, A., Laureys, G., Havrdova, E., Horakova, D., Izquierdo, G., Eichau, S., Ozakbas, S., Alroughani, R., Kalincik, T., Duquette, P., Girard, M., Petersen, T., Patti, F., Csépány, T., Granella, F., Grand'Maison,, F., Ferraro, D., Karabudak, R., José Sá, M., Trojano, M., Pesch, V., Wijmeersch, B., Cartechini, E., McCombe, P., Gerlach, O., Spitaleri, D., Rózsa, C., Hodgkinson, S., Bergamaschi, R., Gouider, R., Soysal, A., Prevost, J., Garber, J., de Gans, K., Ampapa, R., Simó, M., Sanchez-Menoyo, J., Iuliano, G., Sas, A., Walt, A., John, N., Gray, O., Hughes, S., De Luca, G., Onofrj, M., Buzzard, K., Skibina, O., Terzi, M., Slee, M., Solaro, C., Ramo-Tello, C., Fragoso, Y., Shaygannejad, V., Moore, F., Rajda, C., Aguera-Morales, E., Butzkueven, H.: Comparative effectiveness and cost-effectiveness of natalizumab and fingolimod in rapidly evolving severe relapsing-remitting multiple sclerosis in the United Kingdom.
J Med Econ. 27 (1), 109-125, 2024.

Bicskó, R., Illés, Á., Hevessy, Z., Ivády, G., Kerekes, G., Méhes, G., Csépány, T., Gergely, L.: Eculizumab Treatment of Massive Hemolysis Occurring in a Rare Co-Existence of Paroxysmal Nocturnal Hemoglobinuria and Myasthenia Gravis.
Hematol Rep. 16 (2), 255-259, 2024.

De Brouwer, E., Becker, T., Werthen-Brabants, L., Dewulf, P., Iliadis, D., Dekeyser, C., Laureys, G., Wijmeersch, B., Popescu, V., Dhaene, T., Deschrijver, D., Waegeman, W., De Baets, B., Stock, M., Horakova, D., Patti, F., Izquierdo, G., Eichau, S., Girard, M., Prat, A., Lugaresi, A., Grammond, P., Kalincik, T., Alroughani, R., Grand'Maison,, F., Skibina, O., Terzi, M., Lechner-Scott, J., Gerlach, O., Khoury, S., Cartechini, E., Pesch, V., Sá, M., Weinstock-Guttman, B., Blanco, Y., Ampapa, R., Spitaleri, D., Solaro, C., Maimone, D., Soysal, A., Iuliano, G., Gouider, R., Castillo Triviño, T., Sanchez-Menoyo, J., Laureys, G., Walt, A., Oh, J., Aguera-Morales, E., Altintas, A., Al-Asmi, A., de Gans, K., Fragoso, Y., Csépány, T., Hodgkinson, S., Deri, N., Al-Harbi, T., Taylor, B., Gray, O., Lalive, P., Rózsa, C., McGuigan, C., Kermode, A., Sempere, P., Simu, M., Simó, M., Hardy, T., Decoo, D., Hughes, S., Grigoriadis, N., Sas, A., Vella, N., Moreau, Y., Peeters, L.: Machine-learning-based prediction of disability progression in multiple sclerosis: an observational, international, multi-center study.
PLOS Digit. Health. 3 (7), 1-25, 2024.

Siriratnam, P., Sanfilippo, P., Walt, A., Sharmin, S., Foong, Y., Yeh, W., Zhu, C., Khoury, S., Csépány, T., Willekens, B., Etemadifar, M., Ozakbas, S., Nytrova, P., Altintas, A., Al-Asmi, A., Yamout, B., Laureys, G., Patti, F., Simó, M., Surcinelli, A., Foschi, M., McCombe, P., Alroughani, R., Sanchez-Menoyo, J., Turkoglu, R., Soysal, A., Lechner Scott, J., Kalincik, T., Butzkueven, H., Jokubaitis, V., Huda, S., Monif, M., MSBase Study Group: Predictors of relapse risk and treatment response in AQP4-IgG positive and seronegative NMOSD: multicentre study.
J. Neurol. Neurosurg. Psychiatry. [Epub ahead of print]2024.

Siriratnam, P., Huda, S., Walt, A., Sanfilippo, P., Sharmin, S., Foong, Y., Yeh, W., Zhu, C., Khoury, S., Csépány, T., Willekens, B., Etemadifar, M., Ozakbas, S., Nytrova, P., Altintas, A., Al-Asmi, A., Ramo-Tello, C., Laureys, G., Patti, F., Horakova, D., Foschi, M., Boz, C., McCombe, P., Turkoglu, R., Lechner-Scott, J., Roos, I., Kalincik, T., Jokubaitis, V., Butzkueven, H., Monif, M., MSBase Study Group: Prevalence of Progression Independent of Relapse Activity and Relapse-Associated Worsening in Patients With AQP4-IgG-Positive NMOSD.
Neurology. 103 (12), 1-8, 2024.

Dekeyser, C., Hautekeete, M., Cambron, M., Pesch, V., Patti, F., Kuhle, J., Khoury, S., Lechner Scott, J., Gerlach, O., Lugaresi, A., Maimone, D., Surcinelli, A., Grammond, P., Kalincik, T., Habek, M., Willekens, B., Macdonell, R., Lalive, P., Csépány, T., Butzkueven, H., Boz, C., Tomassini, V., Foschi, M., Sanchez-Menoyo, J., Altintas, A., Mrabet, S., Iuliano, G., Sá, M., Alroughani, R., Karabudak, R., Aguera-Morales, E., Gray, O., de Gans, K., Walt, A., McCombe, P., Deri, N., Garber, J., Al-Asmi, A., Skibina, O., Duquette, P., Cartechini, E., Spitaleri, D., Gouider, R., Soysal, A., Van Hijfte, L., Slee, M., Amato, M., Buzzard, K., Laureys, G.: Routine CSF parameters as predictors of disease course in multiple sclerosis: an MSBase cohort study.
J. Neurol. Neurosurg. Psychiatry. 95 (11), 1021-1031, 2024.

Roos, I., Diouf, I., Sharmin, S., Horakova, D., Havrdova, E., Patti, F., Shaygannejad, V., Ozakbas, S., Izquierdo, G., Eichau, S., Onofrj, M., Lugaresi, A., Alroughani, R., Prat, A., Girard, M., Duquette, P., Terzi, M., Boz, C., Grand'Maison,, F., Sola, P., Ferraro, D., Grammond, P., Turkoglu, R., Buzzard, K., Skibina, O., Yamout, B., Altintas, A., Gerlach, O., Pesch, V., Blanco, Y., Maimone, D., Lechner-Scott, J., Bergamaschi, R., Karabudak, R., McGuigan, C., Cartechini, E., Barnett, M., Hughes, S., Sá, M., Solaro, C., Ramo-Tello, C., Hodgkinson, S., Spitaleri, D., Soysal, A., Petersen, T., Granella, F., de Gans, K., McCombe, P., Ampapa, R., Wijmeersch, B., Walt, A., Butzkueven, H., Prevost, J., Sanchez-Menoyo, J., Laureys, G., Gouider, R., Castillo Triviño, T., Gray, O., Aguera-Morales, E., Al-Asmi, A., Shaw, C., Deri, N., Al-Harbi, T., Fragoso, Y., Csépány, T., Sempere, P., Trevino-Frenk, I., Schepel, J., Moore, F., Malpas, C., Kalincik, T., MSBase Study Group: Comparative effectiveness in multiple sclerosis: A methodological comparison.
Mult. Scler. 29 (3), 326-332, 2023.

Kalincik, T., Sharmin, S., Roos, I., Freedman, M., Atkins, H., Burman, J., Massey, J., Sutton, I., Withers, B., Macdonell, R., Grigg, A., Torkildsen, ø., Bo, L., Lehmann, A., Kubala Havrdova, E., Krasulova, E., Trneny, M., Kozak, T., Walt, A., Butzkueven, H., McCombe, P., Skibina, O., Lechner-Scott, J., Willekens, B., Cartechini, E., Ozakbas, S., Alroughani, R., Kuhle, J., Patti, F., Duquette, P., Lugaresi, A., Khoury, S., Slee, M., Turkoglu, R., Hodgkinson, S., John, N., Maimone, D., José Sá, M., Pesch, V., Gerlach, O., Laureys, G., Van Hijfte, L., Karabudak, R., Spitaleri, D., Csépány, T., Gouider, R., Castillo Triviño, T., Taylor, B., Sharrack, B., Snowden, J., MSBase Study Group: Comparative Effectiveness of Autologous Hematopoietic Stem Cell Transplant vs Fingolimod, Natalizumab, and Ocrelizumab in Highly Active Relapsing-Remitting Multiple Sclerosis.
JAMA Neurol. 80 (7), 702-713, 2023.

Diouf, I., Malpas, C., Sharmin, S., Roos, I., Horakova, D., Kubala Havrdova, E., Patti, F., Shaygannejad, V., Ozakbas, S., Eichau, S., Onofrj, M., Lugaresi, A., Alroughani, R., Prat, A., Duquette, P., Terzi, M., Boz, C., Grand'Maison,, F., Sola, P., Ferraro, D., Grammond, P., Yamout, B., Altintas, A., Gerlach, O., Lechner-Scott, J., Bergamaschi, R., Karabudak, R., Iuliano, G., McGuigan, C., Cartechini, E., Hughes, S., Sá, M., Solaro, C., Kappos, L., Hodgkinson, S., Slee, M., Granella, F., de Gans, K., McCombe, P., Ampapa, R., Walt, A., Butzkueven, H., Sanchez-Menoyo, J., Vucic, S., Laureys, G., Sidhom, Y., Gouider, R., Castillo Triviño, T., Gray, O., Aguera-Morales, E., Al-Asmi, A., Shaw, C., Al-Harbi, T., Csépány, T., Sempere, P., Trevino-Frenk, I., Stuart, E., Kalincik, T.: Effectiveness of multiple disease-modifying therapies in relapsing-remitting multiple sclerosis: causal inference to emulate a multiarm randomised trial.
J. Neurol. Neurosurg. Psychiatry. 94 (12), 1004-1011, 2023.

Árokszállási, T., Balogh, E., Orbán-Kálmándi, R., Pásztor, M., Árokszállási, A., Nagy, E., Belán, I., May, Z., Csépány, T., Csiba, L., Bagoly, Z., Oláh, L.: Elevated Blood Alcohol Concentration Is Associated with Improved Clinical Outcomes of Intravenous Thrombolysis Treatment in Acute Ischemic Stroke Patients: A Retrospective Study.
J Clin Med. 12 (6), 1-13, 2023.

Spelman, T., Horakova, D., Ozakbas, S., Alroughani, R., Onofrj, M., Kalincik, T., Prat, A., Terzi, M., Grammond, P., Patti, F., Csépány, T., Boz, C., Lechner-Scott, J., Granella, F., Grand'Maison,, F., Walt, A., Zhu, C., Butzkueven, H., MSBase Study Group: Switching to natalizumab or fingolimod in multiple sclerosis: comparative effectiveness and effect of pre-switch disease activity.
Mult. Scler. Relat. Disord. 70 1-8, 2023.

Sharmin, S., Roos, I., Simpson-Yap, S., Malpas, C., Sánchez, M., Ozakbas, S., Horakova, D., Havrdova, E., Patti, F., Alroughani, R., Izquierdo, G., Eichau, S., Boz, C., Zakaria, M., Onofrj, M., Lugaresi, A., Weinstock-Guttman, B., Prat, A., Girard, M., Duquette, P., Terzi, M., Amato, M., Karabudak, R., Grand'Maison,, F., Khoury, S., Grammond, P., Lechner-Scott, J., Buzzard, K., Skibina, O., Walt, A., Butzkueven, H., Turkoglu, R., Altintas, A., Maimone, D., Kermode, A., Shalaby, N., Pesch, V., Butler, E., Sidhom, Y., Gouider, R., Mrabet, S., Gerlach, O., Soysal, A., Barnett, M., Kuhle, J., Hughes, S., Sá, M., Hodgkinson, S., Oreja-Guevara, C., Ampapa, R., Petersen, T., Ramo-Tello, C., Spitaleri, D., McCombe, P., Taylor, B., Prevost, J., Foschi, M., Slee, M., McGuigan, C., Laureys, G., Hijfte, L., de Gans, K., Solaro, C., Oh, J., Macdonell, R., Aguera-Morales, E., Singhal, B., Gray, O., Garber, J., Wijmeersch, B., Simu, M., Castillo Triviño, T., Sanchez-Menoyo, J., Khurana, D., Al-Asmi, A., Al-Harbi, T., Deri, N., Fragoso, Y., Lalive, P., Sinnige, L., Shaw, C., Shuey, N., Csépány, T., Sempere, P., Moore, F., Decoo, D., Willekens, B., Gobbi, C., Massey, J., Hardy, T., Parratt, J., Kalincik, T., the MSBase investigators: The risk of secondary progressive multiple sclerosis is geographically determined but modifiable.
Brain. 146 (11), 4633-4644, 2023.

Rajda, C., Rózsa, C., Mike, A., Lovas, G., Mezei, Z., Jakab, G., Ács, P., Rum, G., Simó, M., Jobbágy, Z., Bíró, Z., Trauninger, A., Imre, P., Mátyás, K., Deme, I., Illés, Z., Csépány, T.: Treatment of relapsing multiple sclerosis in Hungary: consensus recommendation from the Hungarian neuroimmunology society.
Orphanet J. Rare Dis. 18 (1), 1-8, 2023.

Diouf, I., Malpas, C., Sharmin, S., Roos, I., Horakova, D., Havrdova, E., Patti, F., Shaygannejad, V., Ozakbas, S., Izquierdo, G., Eichau, S., Onofrj, M., Lugaresi, A., Alroughani, R., Prat, A., Girard, M., Duquette, P., Terzi, M., Boz, C., Grand'Maison,, F., Hamdy, S., Sola, P., Ferraro, D., Grammond, P., Turkoglu, R., Buzzard, K., Skibina, O., Yamout, B., Altintas, A., Gerlach, O., Pesch, V., Blanco, Y., Maimone, D., Lechner-Scott, J., Bergamaschi, R., Karabudak, R., Iuliano, G., McGuigan, C., Cartechini, E., Barnett, M., Hughes, S., Sá, M., Solaro, C., Kappos, L., Ramo-Tello, C., Cristiano, E., Hodgkinson, S., Spitaleri, D., Soysal, A., Petersen, T., Slee, M., Butler, E., Granella, F., de Gans, K., McCombe, P., Ampapa, R., Wijmeersch, B., Walt, A., Butzkueven, H., Prevost, J., Sinnige, L., Sanchez-Menoyo, J., Vucic, S., Laureys, G., Van Hijfte, L., Khurana, D., Macdonell, R., Gouider, R., Castillo Triviño, T., Gray, O., Aguera-Morales, E., Al-Asmi, A., Shaw, C., Deri, N., Al-Harbi, T., Fragoso, Y., Csépány, T., Perez Sempere, A., Trevino-Frenk, I., Schepel, J., Moore, F., Kalincik, T.: Variability of the response to immunotherapy among subgroups of patients with multiple sclerosis.
Eur. J. Neurol. 30 (4), 1014-1024, 2023.

Sharmin, S., Bovis, F., Malpas, C., Horakova, D., Havrdova, E., Izquierdo, G., Eichau, S., Trojano, M., Prat, A., Girard, M., Duquette, P., Onofrj, M., Lugaresi, A., Grand'Maison,, F., Grammond, P., Sola, P., Ferraro, D., Terzi, M., Gerlach, O., Alroughani, R., Boz, C., Shaygannejad, V., Pesch, V., Cartechini, E., Kappos, L., Lechner-Scott, J., Bergamaschi, R., Turkoglu, R., Solaro, C., Iuliano, G., Granella, F., Wijmeersch, B., Spitaleri, D., Slee, M., McCombe, P., Prevost, J., Ampapa, R., Ozakbas, S., Sanchez-Menoyo, J., Soysal, A., Vucic, S., Petersen, T., de Gans, K., Butler, E., Hodgkinson, S., Sidhom, Y., Gouider, R., Cristiano, E., Castillo Triviño, T., Saladino, M., Barnett, M., Moore, F., Rózsa, C., Yamout, B., Skibina, O., Walt, A., Buzzard, K., Gray, O., Hughes, S., Sempere, P., Singhal, B., Fragoso, Y., Shaw, C., Kermode, A., Taylor, B., Simó, M., Shuey, N., Al-Harbi, T., Macdonell, R., Dominguez, J., Csépány, T., Sirbu, C., Sormani, M., Butzkueven, H., Kalincik, T.: Confirmed disability progression as a marker of permanent disability in multiple sclerosis.
Eur. J. Neurol. 29 (8), 2321-2334, 2022.

Brouwer, E., Becker, T., Moreau, Y., Havrdova, E., Trojano, M., Eichau, S., Ozakbas, S., Onofrj, M., Grammond, P., Kuhle, J., Kappos, L., Sola, P., Cartechini, E., Lechner-Scott, J., Alroughani, R., Gerlach, O., Kalincik, T., Granella, F., Grand'Maison,, F., Bergamaschi, R., Sá, M., Wijmeersch, B., Soysal, A., Sanchez-Menoyo, J., Solaro, C., Boz, C., Iuliano, G., Buzzard, K., Aguera-Morales, E., Terzi, M., Trivio, T., Spitaleri, D., Pesch, V., Shaygannejad, V., Moore, F., Oreja-Guevara, C., Maimone, D., Gouider, R., Csépány, T., Ramo-Tello, C., Peeters, L.: Corrigendum to Longitudinal machine learning modeling of MS patient trajectories improves predictions of disability progression: [Computer Methods and Programs in Biomedicine, Volume 208, (September 2021) 106180].
Comput. Meth. Programs Biomed. 213 1-3, 2022.

Roos, I., Malpas, C., Leray, E., Casey, R., Horakova, D., Havrdova, E., Debouverie, M., Patti, F., De Seze, J., Izquierdo, G., Eichau, S., Edan, G., Prat, A., Girard, M., Ozakbas, S., Grammond, P., Zephir, H., Ciron, J., Maillart, E., Moreau, T., Amato, M., Labauge, P., Alroughani, R., Buzzard, K., Skibina, O., Terzi, M., Laplaud, D., Berger, E., Grand'Maison,, F., Lebrun-Frenay, C., Cartechini, E., Boz, C., Lechner-Scott, J., Clavelou, P., Stankoff, B., Prevost, J., Kappos, L., Pelletier, J., Shaygannejad, V., Yamout, B., Khoury, S., Gerlach, O., Spitaleri, D., Pesch, V., Gout, O., Turkoglu, R., Heinzlef, O., Thouvenot, E., McCombe, P., Soysal, A., Bourre, B., Slee, M., Castillo Triviño, T., Bakchine, S., Ampapa, R., Butler, E., Wahab, A., Macdonell, R., Aguera-Morales, E., Cabre, P., Ben Nasr, H., Walt, A., Laureys, G., Van Hijfte, L., Ramo-Tello, C., Maubeuge, N., Hodgkinson, S., Sanchez-Menoyo, J., Barnett, M., Labeyrie, C., Vucic, S., Sidhom, Y., Gouider, R., Csépány, T., Sotoca, J., de Gans, K., Al-Asmi, A., Fragoso, Y., Vukusic, S., Butzkueven, H., Kalincik, T., OFSEP and the MSBase investigators: Disease Reactivation After Cessation of Disease-Modifying Therapy in Patients With Relapsing-Remitting Multiple Sclerosis.
Neurology. 99 (17), e1926-e1944, 2022.

Kokas, Z., Sandi, D., Fricska-Nagy, Z., Füvesi, J., Biernacki, T., Köves, Á., Fazakas, F., Birkás, A., Katona, G., Kovács, K., Milanovich, D., Dobos, E., Kapás, I., Jakab, G., Csépány, T., Bense, E., Mátyás, K., Rum, G., Szolnoki, Z., Deme, I., Jobbágy, Z., Kriston, D., Gerócs, Z., Diószeghy, P., Bors, L., Varga, A., Kerényi, L., Molnár, G., Kristóf, P., Nagy, Z., Sátori, M., Imre, P., Péntek, S., Klivényi, P., Kincses, Z., Vécsei, L., Bencsik, K.: Do Hungarian multiple sclerosis care units fulfil international criteria?.
PLoS One. 17 (3), 1-15, 2022.

Lefort, M., Sharmin, S., Andersen, J., Vukusic, S., Casey, R., Debouverie, M., Edan, G., Ciron, J., Ruet, A., De Seze, J., Maillart, E., Zephir, H., Labauge, P., Defer, G., Lebrun-Frenay, C., Moreau, T., Berger, E., Clavelou, P., Pelletier, J., Stankoff, B., Gout, O., Thouvenot, E., Heinzlef, O., Al-Khedr, A., Bourre, B., Casez, O., Cabre, P., Montcuquet, A., Wahab, A., Camdessanche, J., Maurousset, A., Ben Nasr, H., Hankiewicz, K., Pottier, C., Maubeuge, N., Dimitri-Boulos, D., Nifle, C., Laplaud, D., Horakova, D., Havrdova, E., Alroughani, R., Izquierdo, G., Eichau, S., Ozakbas, S., Patti, F., Onofrj, M., Lugaresi, A., Terzi, M., Grammond, P., Grand'Maison,, F., Yamout, B., Prat, A., Girard, M., Duquette, P., Boz, C., Trojano, M., McCombe, P., Slee, M., Lechner-Scott, J., Turkoglu, R., Sola, P., Ferraro, D., Granella, F., Shaygannejad, V., Prevost, J., Maimone, D., Skibina, O., Buzzard, K., Walt, A., Karabudak, R., Wijmeersch, B., Csépány, T., Spitaleri, D., Vucic, S., Koch-Henriksen, N., Sellebjerg, F., Soerensen, P., Hilt Christensen, C., Rasmussen, P., Jensen, M., Frederiksen, J., Bramow, S., Mathiesen, H., Schreiber, K., Butzkueven, H., Magyari, M., Kalincik, T., Leray, E.: Impact of methodological choices in comparative effectiveness studies: application in natalizumab versus fingolimod comparison among patients with multiple sclerosis.
BMC Med. Res. Methodol. 22 (1), 1-14, 2022.

Biernacki, T., Sandi, D., Füvesi, J., Fricska-Nagy, Z., Kincses, Z., Ács, P., Rózsa, C., Dobos, E., Cseh, B., Horváth, L., Nagy, Z., Csányi, A., Kovács, K., Csépány, T., Vécsei, L., Bencsik, K., Study investigators: The safety and efficacy of fingolimod: real-world data from a long-term, non-interventional study on the treatment of RRMS patients spanning up to 5 years from Hungary.
PLoS One. 17 (4), 1-21, 2022.

Hayden, Z., Bóné, B., Orsi, G., Szots, M., Nagy, F., Csépány, T., Mezei, Z., Rajda, C., Simon, D., Najbauer, J., Illés, Z., Berki, T.: Clinical Characteristics and Outcome of Neuronal Surface Antibody-Mediated Autoimmune Encephalitis Patients in a National Cohort.
Front. Neurol. 12 1-11, 2021.

Roos, I., Leray, E., Frascoli, F., Casey, R., Brown, J., Horakova, D., Havrdova, E., Debouverie, M., Trojano, M., Patti, F., Izquierdo, G., Eichau, S., Edan, G., Prat, A., Girard, M., Duquette, P., Onofrj, M., Lugaresi, A., Grammond, P., Ciron, J., Ruet, A., Ozakbas, S., De Seze, J., Louapre, C., Zephir, H., Sá, M., Sola, P., Ferraro, D., Labauge, P., Defer, G., Bergamaschi, R., Lebrun-Frenay, C., Boz, C., Cartechini, E., Moreau, T., Laplaud, D., Lechner-Scott, J., Grand'Maison,, F., Gerlach, O., Terzi, M., Granella, F., Alroughani, R., Iuliano, G., Pesch, V., Wijmeersch, B., Spitaleri, D., Soysal, A., Berger, E., Prevost, J., Aguera-Morales, E., McCombe, P., Castillo Triviño, T., Clavelou, P., Pelletier, J., Turkoglu, R., Stankoff, B., Gout, O., Thouvenot, E., Heinzlef, O., Sidhom, Y., Gouider, R., Csépány, T., Bourre, B., Al Khedr, A., Casez, O., Cabre, P., Montcuquet, A., Wahab, A., Camdessanche, J., Maurousset, A., Patry, I., Hankiewicz, K., Pottier, C., Maubeuge, N., Labeyrie, C., Nifle, C., Coles, A., Malpas, C., Vukusic, S., Butzkueven, H., Kalincik, T., MSBase and OFSEP study groups: Determinants of therapeutic lag in multiple sclerosis.
Mult. Scler. 27 (12), 1838-1851, 2021.

Kalincik, T., Diouf, I., Sharmin, S., Malpas, C., Spelman, T., Horakova, D., Havrdova, E., Trojano, M., Izquierdo, G., Lugaresi, A., Prat, A., Girard, M., Duquette, P., Grammond, P., Jokubaitis, V., Walt, A., Grand'Maison,, F., Sola, P., Ferraro, D., Shaygannejad, V., Alroughani, R., Hupperts, R., Terzi, M., Boz, C., Lechner-Scott, J., Pucci, E., Pesch, V., Granella, F., Bergamaschi, R., Spitaleri, D., Slee, M., Vucic, S., Ampapa, R., McCombe, P., Ramo-Tello, C., Prevost, J., Olascoaga, J., Cristiano, E., Barnett, M., Saladino, M., Sanchez-Menoyo, J., Hodgkinson, S., Rózsa, C., Hughes, S., Moore, F., Shaw, C., Butler, E., Skibina, O., Gray, O., Kermode, A., Csépány, T., Singhal, B., Shuey, N., Piroska, I., Taylor, B., Simó, M., Sirbu, C., Sas, A., Butzkueven, H., MSBase Study Group: Effect of Disease-Modifying Therapy on Disability in Relapsing-Remitting Multiple Sclerosis Over 15 Years.
Neurology. 96 (5), e783-e797, 2021.

De Brouwer, E., Becker, T., Moreau, Y., Havrdova, E., Trojano, M., Eichau, S., Ozakbas, S., Onofrj, M., Grammond, P., Kuhle, J., Kappos, L., Sola, P., Cartechini, E., Lechner-Scott, J., Alroughani, R., Gerlach, O., Kalincik, T., Granella, F., Grand'Maison,, F., Bergamaschi, R., José Sá, M., Wijmeersch, B., Soysal, A., Sanchez-Menoyo, J., Solaro, C., Boz, C., Iuliano, G., Buzzard, K., Aguera-Morales, E., Terzi, M., Trivio, T., Spitaleri, D., Pesch, V., Shaygannejad, V., Moore, F., Oreja-Guevara, C., Maimone, D., Gouider, R., Csépány, T., Ramo-Tello, C., Peeters, L.: Longitudinal machine learning modeling of MS patient trajectories improves predictions of disability progression.
Comput. Meth. Programs Biomed. 208 1-14, 2021.

Merő, G., Móser, J., Liptai, Z., Diószeghy, P., Bessenyei, M., Csépány, T.: Magas aktivitású sclerosis multiplex hatásos kezelése gyermekkorban.
Ideggyogy. Szle. 74 (11-12), 413-424, 2021.